Muhammad Dzakwan


Pendahuluan : Morin (3,5,7, 2,4’- pentahidroksiflavone) adalah senyawa flavonoid golongan flavonol yang poten sebagai antioksidan, antikanker, antiinflamasi dan sebagai antidiabetes. Morin bersifat lipofil, tidak larut dalam air sehingga ketersediaan hayati dan aplikasi klinis menjadi terbatas. Nanosuspensi adalah sistem dispersi koloidal, 100% mengandung bahan obat dengan ukuran 10-1000 nm, tidak mengandung bahan pembawa apapun kecuali sebagai bahan penstabil. Tujuan : Penelitian ini bertujuan membuat nanosuspensi morin yang stabil dengan metode sonopresipitasi. Karakterisasi nanosuspensi meliputi ukuran partikel, indeks polidispersitas, zeta potensial, morfologi nanosuspensi dan aktivitas antioksidan. Metode : Nanosuspensi morin dibuat dengan metode sonopresipitasi dengan frekuensi 50 kHz selama 8 menit dengan variasi bahan penstabil jenis surfaktan, polimer dan kombinasi keduanya. Karakterisasi nanosuspensi meliputi ukuran partikel, indeks polidispersitas, zeta potensial, morfologi partikel (TEM), stabilitas fisik dan aktivitas antioksidan. Kesimpulan : Morin berhasil dikembangkan menjadi nanosuspensi dengan metode sonopresipitasi. Formula 7 dengan stabilizer SLS-Pluronic F68 (0,5:1) merupakan  formula terpilih dengan ukuran partikel terkecil sebesar 182,7 nm, ukuran partikel seragam (PI : 0,210), stabil setelah penyimpanan 8 minggu dengan nilai zeta potensial -37,8 mV. Aktivitas antioksidan nanosuspensi morin meningkat sebesar 2-3 kali



Nanosuspensi, morin, sonopresipitasi, stabil, antioksidan

Full Text:



Al-Numair K S, Chandramohan G, Alsaif M A, Veeramani C and El-Newehy A S., 2014. Morin, a Flavonoid, on Lipid Peroxidation and Antioxidant Status in Experimental Myocardial Ischemic Rats, Afr J Tradit Complement Altern Med, 11(3):14–20.

Al-Sharari S D, Al-Rejaie S S, Abuohashish H M, Aleisa A M, Parmar M Y and Ahmed M M., 2014. Ameliorative Potential of Morin in Streptozotocin-Induced Neuropathic Pain in Rats, Trop. J. Pharm. Res, 13: 1429–1436.

Al-Kassas R, Bansal M and Shaw J., 2017. Nanosizing Techniques for Improving Bioavailability of Drugs, J Control Release, 28 (260):202–212

Arriagada F, Correa O, Gunther G, Nonell S, Mura F, Olea-Azar C and Morales J.,2016. Morin Flavonoid Adsorbed on Mesoporous Silica, A Novel Antioxidant Nanomaterial, PLoS ONE, 11(11): 1-22

Bhavin Y, Gajera B Y, Shah D A and Dave R H., 2019. Development of an Amorphous Nanosuspension by Sonoprecipitation-Formulation and Process Optimization using Design of Experiment methodology, International Journal of Pharmaceutics, 559: 348-359

Caselli A, Ciri P, Santi, A and Paoli, P., 2016. Morin: A Promising Natural Drug, Current Medicinal Chemistry, 23 (12): 1-18

Caselli A, Cirri P, Santi A and Paoli P., 2016. Morin: Apromising Natural Drug, Curr Med Chem, 23, 774–791.

Da Silva F L O, De Freitas Marques, M B, Cato C K and Carneiro G., 2020. Nanonization Techniques to Overcome Poor Watersolubility with Drugs, Expert Opinion on Drug Discovery, 15(5): 1-12

Dinh-Tran T T, Lien-Tran P H, Nguyen M N U, Tran K T M, Pham M N, Tran P C and Vo T V., 2014. Amorphous Isradipine Nanosuspension by the Sonoprecipitation Methode, International Journal of Pharmaceutics, 474 (1-2): 146-150

Dzakwan M, Pramukantoro G E, Mauludin R and Wikarsa S., 2017. Formulation and characterization of fisetin nanosuspension, Materials Science and Engineering, 259 (012016): 1-5

Du J, Li X, Zhao H, Zhou Y, Wang L, Tian S and Wang Y., 2015. Nanosuspensions of Poorly Water Soluble Drugs Prepared by Bottom-Up Technologies, International Journal of Pharmaceutics, 495(1-2): 738-749

Dizaj S M, Vazifehasl Z and Salatin S., 2015. Nanosizing of Drugs: Effect on Dissolution Rate, Res Pharm Sci, 10(2):95–108

Ezeddin K., 2013. Nanodispersions Platform for Solubility Improvement, International Journal of Research in Pharmaceutical and Biomedical Sciences, 4 (2): 636-643.

Esfandi E, Ramezani V and Moghaddam S P H.,2016. Clarithromycin Dissolution Enhancement by Preparation of Aqueous Nanosuspensions Using Sonoprecipitation Technique, Iranian Journal of Pharmaceutical Research, 13(3): 809-818

Fairhust D and Lee R W., 2011. The Zeta Potential & its Use in Pharmaceutical Applications - Part 1: Charged Interfaces in Polar & Non-Polar Media & the Concept of the Zeta Potential, Drug Development and Delivery, 11(6): 60-64

Fang S H, Hou Y C, Hsiu S I, Ghao P D, Chiang B I., 2003. Morin Sulfate / Glucorinides Exert Anti-inflammatory Activity on Activated Macrophages and Decreased in the Incidence of Septic Shock, Life Science, 74:743-756

Fan M, Geng S and Liu Y., 2018. Nanocrystal Technology as A Strategy to Improve Drug Bioavailability and Antitumor Efficacy for the Cancer Treatment, Curr Pharm Des, 24(21):2416–2424.

Gao L, Liu G, Wang X, Lie F, Xu Y and Ma J., 2011. Preparation of a Chemically Stable Quercetin Formulation Using Nanosuspension Technology, International Journal of Pharmaceutics, 404: 231-237

Ghost I, Bose S, Vippagunta R and Harmon F., 2011. Nanosupension for Improving the Bioavailability of a Poorly Soluble Drug and Screening of Stabilizing Agents to Inhibit Crystal Growth, International Journal of Pharmaceutics, 409: 260-268

Jahan N, Aslam S, Rahman K U, Fazala T, Anwar F and Sahera R.,2016. Formulation and Characterisation of Nanosuspension of Herbal Extracts for Enhanced Antiradical Potential, Journal of Experimental Nanoscience, 11(1): 72-80

Ji Y Y and Lee H S., 2012. Evaluation of Antioxidant and Antibacterial Activities of Morin Isolated from Mulberry Fruits (Morus alba L), Journal of The Korean Society for Applied Biological Chemistry, 55: 485-489

Jiang L, Wang J, Jiang J, Zhang C, Zhao M, Chen Z, Na Wang, Hu D, Liu X, Peng H and Lian M., 2019. Sonodynamic Therapy in Atherosclerosis by Curcumin Nanosuspensions: Preparation design, Efficacy Evaluation, and Mechanisms Analysis, European Journal of Pharmaceutics and Biopharmaceutics, 146: 101 – 110

Jullian C, Orosteguis T, Perez-Cruz, F, Shancez P, Mendizabal F and Olea-Azhar C., 2008. Complexation of Morin With Three Kinds of Cyclodextrin A Thermodinamic and Reactivity Study, Spectrochimia Acta Part A, 71: 269-275

Kumar S, Gokhale R and Burgess D., 2014. Sugars as Bulking Agents to Prevent Nano-crystal Aggregation During Spray or Freeze-drying, International Journal of Pharmaceutics, 471: 303-311

Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, Yang X and Pan W.,2012. Fabrication of Carvedilol Nanosuspensions Through the Anti-Solvent Precipitation–Ultrasonication Method for the Improvement of Dissolution Rate and Oral Bioavailability, AAPS PharmSciTech, 13(1): 295-304

Liu Y T, Hao H P, Xie H G, Lai L, Wang Q, Liu C X and Wang G J., 2010. Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats, Drug Metab. Dispos, 38: 1779–1784

Li J, Yang Y, Ning E, Peng Y and Zhang J., Mechanisms of Poor Oral Bioavailability of Flavonoid Morin in Rats: From Physicochemical to Biopharmaceutical Evaluations, European of Journal Pharmaceutics Sciences, 128: 290-298

Lima B D S, Campos C D A, da Silva Santos A C R, Santos V C N, Trindade G D G G, Shanmugam S, Pereira E W M, Marreto R V, Duarte M C, da Silva Almeida J R G, Quintans J D S S, Quintans Jr L J and Araujo A A D S., 2019. Developmentofmorin/Hydroxypropyl-Β-Cyclodextrin Inclusion Complex: Enhancement of Bioavailability, Antihyperalgesic and anti-Inflammatory Effects, Food and Chemical Toxicology, 126: 15-24

MadanKumar P, NaveenKumar P, Devaraj H, and NiranjalaiDevaraj, S., 2015. Morin, a Dietary Flavonoid, Exhibit Anti-Fibrotic Effect and Induces Apoptosis of Activated Hepatic Stellate Cells by Supressing Canonical NF-kB Signaling, Biochimie, 110: 107-118

Markovic Z, Milenkovic D, Dorovic J, Markovic J M D, Stepanic V, Lucic B and Amic D., 2012. Free Radical Scavenging Activity of Morin 2’-O-Phenoxide Anion, Food Chemistry, 135: 2070-2077

Mendoza-Wilson A M, Santacruz-Ortega H and Quintana R R B., 2011. Relationship Between Structure, Properties and Radical Scavenging Activity of Morin, Journal of Molecular Structure, 995: 134-141

Malamatari M, Taylor K M G and Malamataris S., 2018. Pharmaceutical Nanocrystals: Production by Wet Milling and Applications, Drug Discov Today, 23(3):534–547

Purkayastha H D and Imanur Hossian S K., 2019. Nanosuspension: A Modern Technology Used In Drug Delivery System, International Journal of Current Pharmaceutical Research, 11(3): 1-3

Patel H M, Patel B B and Shah C N., 2016. Nanosuspension: A novel approch to enhance solubility of poorly water soluble drugs - A review, International Journal of Advances in Pharmaceutics, 5(2): 21-19

Sharmaa S H, Kumara J S, Chellappanb D R and Nagarajana, S., 2018. Molecular Chemoprevention by Morin – A Plant Flavonoid that Targets Nuclear Factor Kappa B in Experimental Colon Cancer, Biomedicine & Pharmacotherapy, 100: 367-373

Sultana F, Neog M K, and Khan Rasool M K., 2017. Targeted Delivery of Morin, A Dietary Bioflavanol Encapsulated Mannosylated Liposomes to the Macrophages of Adjuvant-Induced Arthritis Rats Inhibits Inflammatory Immune Response and Osteoclastogenesis, European Journal of Pharmaceutics and Biopharmaceutics, 115: 229-242

Thangarajan S, Vedagiri A, Somasundaram S, Sakthimanogaran R and Murugesan, M., 2018. Neuroprotective Effect of Morin on Lead Acetate- Induced Apoptosis by Preventing Cytochrome C Translocation Via Regulation of Bax/Bcl-2 Ratio, Neurotoxicology and Teratology, 66:35-45

Verma S, Kumar S, Gokhale R and Burgess D J., 2011. Physical Stability of Nanosuspension : Investigation of the Role Stabilizers on Ostwald Ripening, International Journal of Pharmaceutics, 406: 145-152

Waddad A Y, Abad S, Yu F, Munyendo W L L, Wang J, Huixia L and Zhou J., 2013. Formulation, Characterization and Pharmacokinetics of Morin Hydrate Niosome Prepared from Various Non- Ionic Surfactans, International Journal of Pharmaceutics, 456(2): 446-458

Yazdanshenas R and Gharib F., 2017. Solubility and Thermodynamic Functions Measurement of Morin Hydrate in Different Alcohol, Journal of Molecular Liquids, 233:9-14

Yong H J and Ahn J J., 2018. Antioxidant and Skin Protection Effect of Morin Upon UV-A Exposure, Biomedical Dermatology, 2(12):2-7

Yu J, Wan K and Sun, X., 2017. Improved Transdermal Delivery of Morin Efficiently Inhibits Allergic Contact Dermatitis, International Journal of Pharmaceutics, 530(1-2): 145-154

Zeng C, Zheng R and Yang X., 2019. Improved Oral Delivery of Tilianin Through Lipid-Polymer Hybrid Nanoparticles to Enhance Bioavailability, Biochem Biophys Res Commun, 519 (2):316–322

Zhang J, Peng Q, Shi S, Zhang Q, Sun X, Gong T and Zhang Z., 2011. Preparation, Characterization and In Vivo Evaluation of a Self Nanoemulsion Drug Delivery System Loaded with Morin Phospolipid Complex, Int. J. Nanomedicine, 6: 3405-3414

Zhaoa J, Yang J and Xiea Y., 2019. Improvement Strategies for the Oral Bioavailability of Poorly Water-Soluble Flavonoids : Anoverview, International Journal of Pharmaceutics, 570: 1-21



  • There are currently no refbacks.

Indexed and Journal List Title by :


CiteFactorResearch BIB
MorarefDRJIESJIEuroPubScientific Indexing Services
CrossRefPortal GarudaWorldCatScilitIndonesia One Search

Free counters!
Visitor since 20 December 2018 :

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License